| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 04/02/2002 | US6365178 Method of making pressure sensitive adhesive matrix patches for transdermal drug delivery using hydrophilic salts of drugs and hydrophobic pressure sensitive adhesive dispersions |
| 04/02/2002 | US6365177 Insulin supplemented infant formula |
| 04/02/2002 | US6365174 Wettable powder compositions of ionophore antibiotics |
| 04/02/2002 | US6365173 Polymeric carrier for delivery of bioactive or bioreactive molecule, comprising stereocomplex of at least one biocompatible stereoselective polymer and bioactive or bioreactive molecule |
| 04/02/2002 | US6365171 Amphiphilic networks, implantable immunoisolatory devices and methods of preparation |
| 04/02/2002 | US6365166 Inducing interferon and tumor necrosis factor locally in the skin or mucous memebranes by applying 4-amino-2-ethoxymethyl-alpha,alpha-di methyl-1h-imidazo(4,5-c)quinoline-1-ethanol, silica sol, triacetin and propylene glycol |
| 04/02/2002 | US6365164 Injecting therapeutic amount of botulinum toxin into prostate gland of patient, thereby alleviating symptoms of prostatic hyperplasia, benign prostatic hyperplasia or prostatic enlargement |
| 04/02/2002 | US6365156 Contacting mucosal membrane of animal with chimeric molecule comprising viral-specific ligand and bacterial-specific ligand which is specific for bacteria colonizing membrane |
| 04/02/2002 | US6365148 Spray coating grains; sustained release |
| 04/02/2002 | US6365146 Polyamideester copolymer |
| 04/02/2002 | US6365145 Using liposome; applying light |
| 04/02/2002 | US6365131 Pharmaceutical dental formulation for topical application of metronidazole benzoate, chlorhexidine gluconate and local anesthetic |
| 04/02/2002 | US6364893 Stent lining |
| 04/02/2002 | CA2249039C Iontophoretic patch with hydrogel reservoir |
| 04/02/2002 | CA2213700C Pharmaceutical composition for piperidinoalkanol compounds |
| 04/02/2002 | CA2056066C A physical form of n-[4-[5-(cyclopentyloxycarbony)amino-1-methylindol-3yl-methy1]-3-methoxybenzoy1]-2-methlbenzenesulphonamide, processes for its preparation and compositions containing it |
| 03/29/2002 | WO2002066039A1 Anticancer agent |
| 03/29/2002 | CA2357998A1 Composition to enhance permeation of topical skin agents |
| 03/28/2002 | WO2002025194A1 Drying method for selectively removing volatile components from wet coatings |
| 03/28/2002 | WO2002024891A2 B7-like molecules and uses thereof |
| 03/28/2002 | WO2002024832A1 Aggregate-forming agent |
| 03/28/2002 | WO2002024717A1 Antisense modulation of flip-c expression |
| 03/28/2002 | WO2002024623A2 Novel alkanoic acid derivatives |
| 03/28/2002 | WO2002024319A1 Microcapsule powder |
| 03/28/2002 | WO2002024239A1 Method and hemostatic patch for effecting local hemostasis |
| 03/28/2002 | WO2002024230A1 Solid preparations |
| 03/28/2002 | WO2002024207A1 Diuretic or sulphonylurea for use in antiviral treatment |
| 03/28/2002 | WO2002024203A2 Controlled release formulations for oral administration |
| 03/28/2002 | WO2002024202A1 Nasal delivery of apomorphine in combination with glycol derivatives |
| 03/28/2002 | WO2002024201A1 Method of treating aquatic animals with an antimicrobial agent and chelating agent |
| 03/28/2002 | WO2002024193A1 Stabilised fibrate microparticles |
| 03/28/2002 | WO2002024185A2 Topical analgesic compositions containing aliphatic polyamines and methods of using same |
| 03/28/2002 | WO2002024184A2 Mechanically stable dosage forms containing ubiquinones |
| 03/28/2002 | WO2002024180A2 Chromium containing compositions for the treatment of diabetes, the reduction of body fat, improvement of insulin sensitivity and reduction of hyperglycemia and hypercholesteremia |
| 03/28/2002 | WO2002024175A2 Pharmaceutical formulation for pulmonary or nasal administration |
| 03/28/2002 | WO2002024174A2 Sustained release composition containing clarithromycin |
| 03/28/2002 | WO2002024173A2 Oral dosage forms of boswellia extracts |
| 03/28/2002 | WO2002024172A1 Pharmaceutical semi-solid composition of isotretinoin |
| 03/28/2002 | WO2002024171A1 Novel formulation for counteracting an ethylene response in plants, preparation process thereof, and method using the same |
| 03/28/2002 | WO2002024170A1 Pharmaceutical compositions for rectal and vaginal administration |
| 03/28/2002 | WO2002024169A1 Spray drying process and compositions of fenofibrate |
| 03/28/2002 | WO2002024168A1 Process for producing medicinal solid dispersion |
| 03/28/2002 | WO2002024167A1 Medicinal composition |
| 03/28/2002 | WO2002024166A1 Oral preparations with favorable disintegration characteristics |
| 03/28/2002 | WO2002024165A2 Preparation of vitamin emulsions and concentrates thereof |
| 03/28/2002 | WO2002024164A2 Method for granulation of active substances by low pressure extrusion to obtain directly compressible granules |
| 03/28/2002 | WO2002024163A1 Solid dose nanoparticulate compositions |
| 03/28/2002 | WO2002024162A1 Phosphatidylserine-carrying apoptosis-mimicking bodies and the use thereof in medical treatment |
| 03/28/2002 | WO2002024161A1 Suppositories sustained in the lower rectum |
| 03/28/2002 | WO2002024160A2 Long acting antidepressant microparticles |
| 03/28/2002 | WO2002024159A2 Implantable drug delivery patch |
| 03/28/2002 | WO2002024158A2 Pulmonary delivery in treating disorders of the central nervous system |
| 03/28/2002 | WO2002024157A2 Acryl adhesive useful in transdermal drug delivery systems |
| 03/28/2002 | WO2002024154A2 Method for topical treatment of anthralin-responsive dermatological disorders |
| 03/28/2002 | WO2002024152A2 Oil in glycerin emulsion |
| 03/28/2002 | WO2002024150A2 Ultrasonic method and device for wound treatment |
| 03/28/2002 | WO2002024146A2 Methods of decreasing or preventing pain using spicamycin derivatives |
| 03/28/2002 | WO2002024143A2 Treating microbial infection of skin lesions |
| 03/28/2002 | WO2002024116A1 Self-preserved nasal, inhalable, and topical ophthalmic preparations and medications |
| 03/28/2002 | WO2002024100A1 Concurrent tooth repositioning and substance delivery |
| 03/28/2002 | WO2002024059A1 Methods for treating various eye disorders |
| 03/28/2002 | WO2002023995A1 Method of blocking free radical processes which result in media ted pathology without deleterious pro-oxidant side reactions |
| 03/28/2002 | WO2002015882A8 Delayed release compositions and combinations |
| 03/28/2002 | WO2002002056A3 Method of treatment of seborrheic dermatitis |
| 03/28/2002 | WO2001092400A3 Highly flexible starch-based films |
| 03/28/2002 | WO2001091725A3 Biologically useful polyphosphates |
| 03/28/2002 | WO2001090144A3 Vip-related peptides for the treatment of sexual disorders in women |
| 03/28/2002 | WO2001089493A3 Compositions containing a benzamide disulfide derivative for treating allergic diseases |
| 03/28/2002 | WO2001089479A3 Sustained release pharmaceutical compositions for parenteral administration of hydrophilic compounds |
| 03/28/2002 | WO2001087236B1 Topical administration of pharmacological compositions for non-systemic treatment of pruritus |
| 03/28/2002 | WO2001087228A3 Sustained release pharmaceutical composition containing glipizide and method for producing same |
| 03/28/2002 | WO2001085138A3 Particulate encapsulation of liquid beads |
| 03/28/2002 | WO2001082794A3 Fiber optic probe placement guide |
| 03/28/2002 | WO2001080844A3 Method of treating dry eye disease with nicotinic acetylcholine receptor agonists |
| 03/28/2002 | WO2001080822A3 Effervescent granules and methods for their preparation |
| 03/28/2002 | WO2001078706A3 Treatment of hyperproliferative, inflammatory and related mucocutaneous disorders using inhibitors of mevalonate synthesis and metabolism |
| 03/28/2002 | WO2001078689A3 Particulate composition |
| 03/28/2002 | WO2001076575A3 The treatment of respiratory diseases |
| 03/28/2002 | WO2001076370A3 Anthelmintic combinations |
| 03/28/2002 | WO2001072279A3 Medical emulsion for lubrication and delivery of drugs |
| 03/28/2002 | WO2001068038A3 System for the controlled delivery of an active material to a dental site |
| 03/28/2002 | WO2001064524A3 Metered dose inhaler |
| 03/28/2002 | WO2001064273A3 Metered dose inhaler |
| 03/28/2002 | WO2001058866A3 Ocular hypotensive lipids |
| 03/28/2002 | WO2001051032A3 Micronized freeze-dried particles |
| 03/28/2002 | WO2001049687A3 Cyclohexene nucleic acids |
| 03/28/2002 | WO2001038552A3 Excipient system that contains coating substances with enzymatically removable side-groups |
| 03/28/2002 | WO2001023377A9 Polymorphic salt |
| 03/28/2002 | WO2001015677A3 Use of 5-ht1b/1d agonists to treat otic pain |
| 03/28/2002 | WO2000061611A9 Production of attenuated chimeric respiratory syncytial virus vaccines from cloned nucleotide sequences |
| 03/28/2002 | WO2000060051A3 Arpe-19 as a platform cell line for encapsulated cell-based delivery |
| 03/28/2002 | US20020038137 Therapeutic treatment of disorders based on timing information |
| 03/28/2002 | US20020038032 Orally administrable acid stable antiulcer benzimidazole derivatives |
| 03/28/2002 | US20020037986 Amphiphilic copolymer planar membranes |
| 03/28/2002 | US20020037977 Polymer and plasticizing agent are capable of hydrogen or electrostatic bonding to each other and are present in a specific ratio |
| 03/28/2002 | US20020037940 Mixing polymer and monomer comprising first catechol group and reactive group, oxidizing, polymerizing monomer via first catechol group and reactive group to form polymer in which first catechol group has been oxidized to quinone group |
| 03/28/2002 | US20020037933 Sterile pharmaceutical for parenteral administration which comprises the compound 2,6-diisopropylphenol (propofol) with a sterile diluent or carrier; counteracting endotoxin induced deterioration of arterial oxygen tension |
| 03/28/2002 | US20020037919 Compositions and methods of paclitaxel for preventing psoriasis |
| 03/28/2002 | US20020037899 Compositions containing an inhibitor of dihydrofolate reductase and a folate |
| 03/28/2002 | US20020037898 Nutrient such as vitaminb 6 in the form of an ester, and a co-ester such as butyl benzoate which inhibits esterases; delivery to cells; bioavailability |